STDs

;

Comments on USPSTF draft research plan on PrEP

Jan 17, 2023

The HIV+Hepatitis Policy Institute thanks you for the opportunity to comment on the U.S. Preventive Services Task Force (USPSTF) Draft Recommendation Statement: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis (PrEP). On October 1, 2022, HIV+Hep submitted a request, supported by 62 additional organizations, asking the USPSTF to update the existing PrEP recommendation to include long-acting injectable PrEP. We commend you for conducting and completing this timely and thorough update.

read more

Comments in support of hepatitis B universal adult vaccination

Sep 24, 2021

HIV+Hep strongly supports a recommendation for universal hepatitis B vaccination for all adults. The hepatitis B vaccine is safe and effective, with over 1 billion doses administered worldwide and is estimated to have prevented over 310 million infections worldwide between 1990 and 2020. Despite highly effective vaccines, up to 2.4 million people in the United States may be living with chronic hepatitis B, and there are up to 80,000 new cases of hepatitis B each year. With the proper guidance and resources, each new infection is preventable.

read more

Comments recommending PrEP in STI counseling and Well-Woman Preventive Visits

Sep 14, 2021

The HIV+Hepatitis Policy Institute submitted the following comments to the Women’s Preventive Services Institute recommending that HIV preexposure prophylaxis (PrEP) be included for all women at risk of HIV as part of sexually transmitted infection counseling and as part of the Well-Woman Preventive visits, as they update HRSA’s recommended preventive services for women.

read more

Search

Categories

Tags

ACA Appropriations Biden administration CDC co-pay accumulators Congress copay copay accumulator Copay accumulators Copay assistance Cost-sharing COVID-19 Drug Pricing FDA Gay men healthcare Hepatitis Hepatitis B hepatitis C Hepatitis Prevention HHS HIV HIV Prevention Insurers Medicaid medicare Medicare Part D NAIC NIH PBM PBMs PrEP Prescription Drugs Private Insurance Ryan White Program state STDs Syringe services Testing transparency Treatment Trump administration women

Recent Testimony, Letters, Comments

Pin It on Pinterest